Routine use of a spike-in DNA in-process control for foetal RHD genotyping: Testing the real-world effectiveness of this 'canary'
{{output}}
Background and objectives: Non-invasive foetal RHD (fRHD) genotyping is widely implemented to prevent unnecessary administration of antenatal anti-D prophylaxis. Reliable assay performance is critical. In line with expert recomme... ...
